VTGN · Vistagen Therapeutics, Inc.
$0.27
+0.00 (+0.49%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of August 14, 2026, the issuance date of the condensed consolidated financial statements as of and for the three months ended June 30, 2026, there is uncertainty about whether the Company's combined cash, cash equivalents, and marketable securities will be sufficient to fund operations beyond twelve months from the issuance date of these condensed consolidated financial statements and therefore the Company concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$11.88M
Shares
44.38M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-14 | — | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-08-05 | 2026-08-04 | |
| DEF 14A | 2026-07-31 | — | |
| 8-K | 2026-07-31 | 2026-07-29 | |
| 8-K | 2026-06-30 | — | |
| 8-K | 2026-06-17 | 2026-06-16 | |
| 10-K | 2026-06-15 | 2026-03-31 | |
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-06-09 | — | |
| 8-K | 2026-05-19 | 2026-05-18 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-08 | — | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| 8-K | 2026-04-13 | 2026-04-07 | |
| 8-K | 2026-04-02 | 2026-04-01 | |
| 8-K | 2026-03-18 | 2026-03-17 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-11 | 2026-03-05 | |
| 8-K | 2026-02-20 | 2026-02-13 | |
| 10-Q | 2026-02-12 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-02-06 | 2026-02-03 | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-12-22 | 2025-12-17 | |
| 8-K | 2025-12-03 | 2025-11-28 | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-11-04 | 2025-11-03 | |
| 8-K | 2025-10-29 | 2025-10-27 | |
| 8-K | 2025-09-15 | 2025-09-09 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| DEF 14A | 2025-07-28 | 2025-09-09 | |
| 8-K | 2025-06-25 | 2025-06-23 | |
| 10-K | 2025-06-17 | 2025-03-31 | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-03-06 | 2025-03-03 | |
| 10-Q | 2025-02-13 | 2024-12-31 | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2025-01-13 | 2025-01-10 | |
| 8-K | 2024-12-06 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-23 | — | |
| 8-K | 2024-08-28 | 2024-08-26 |
Showing 1–50 of 186 filings
Key facts
CIK
1411685
CUSIP
92840H400
13F (30d)
57 filings
56 filers
Visit website
Investor relations